MedPath
HSA Approval

FEBUGOUT F.C. TABLETS 80MG

SIN17054P

FEBUGOUT F.C. TABLETS 80MG

FEBUGOUT F.C. TABLETS 80MG

July 25, 2024

MIRACO NUTRIPHARM PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMIRACO NUTRIPHARM PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

M04AA03

Manufacturer Information

MIRACO NUTRIPHARM PTE. LTD.

Standard Chem. & Pharm. Co., Ltd.

Active Ingredients

Febuxostat

80mg

Febuxostat

Documents

Package Inserts

Febugout F.C. Tablets PI.pdf

Approved: July 25, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FEBUGOUT F.C. TABLETS 80MG - HSA Approval | MedPath